The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.
Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Monday's prices. Each symbol is a hyperlink or shortcut to more information.GILD 1.97%
Market Cap 82 Billion
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.
EPS -0.92 P/E Ratio --
Previous Tue, Jul 30, 2019
Latest Thu, Oct 24, 2019 (25 days ago) Price -2.27%
Yield 3.50% / $2.28
Ex-Date Thu, Dec 13, 2018 (340 days ago)
Pay Date Fri, Dec 28, 2018
History 15 Payments (Quarterly)
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.